Lymphoid malignancies and plasma cell disorders

The 23rd EHA Congress brought many advances in the biology and treatment of lymphoid malignancies and plasma cell disorders. A vast area was covered, from elucidating the mechanisms underlying oncogenic transformation to practice-changing clinical research.

Click on the blocks below to read the full stories, view abstracts, presentations, webcasts and expert interviews.